• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在肝炎高发地区评估甲胎蛋白作为肝细胞癌筛查标志物的作用。

Evaluation of alpha-fetoprotein as a screening marker for hepatocellular carcinoma in hepatitis prevalent areas.

作者信息

Chun Sejong, Rhie Su Yeon, Ki Chang-Seok, Kim Jee Eun, Park Hyung-Doo

机构信息

Department of Laboratory Medicine and Genetics, Samsung Medical Center, Seoul, Republic of Korea.

Center for Health Promotion, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Republic of Korea.

出版信息

Ann Hepatol. 2015 Nov-Dec;14(6):882-8. doi: 10.5604/16652681.1171776.

DOI:10.5604/16652681.1171776
PMID:26436360
Abstract

The objective of this study was to establish modified cutoff values of serum alpha-fetoprotein (AFP) according to hepatitis status. While AFP is used as a serum marker in the diagnosis or monitoring of hepatocellular carcinoma (HCC), its use as a screening method to the general population is controversial. We evaluated its screening performance in a hepatitis prevalent East Asian population, and suggest different cutoff values according to the individual's hepatitis status. We evaluated the performance of AFP as a screening test in 48,123 consecutive Koreans during the period from March, 2012 to August, 2013 who underwent routine health checks at a single institution. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated with fixed cutoff and with modified cutoffs according the individual's hepatitis status. A total of 24 out of 48,123 subject (0.05%) were newly diagnosed with HCC after screening. Among the 1,874 subject with positive hepatitis B virus surface antigen (HBsAg), 17 (0.91%) developed HCC, compared with two out of 393 (0.51%) individuals with hepatitis C virus antibody (anti-HCV). Five out of 45,855 (0.01%) subject with neither HBsAg nor anti-HCV developed HCC. Compared to the performance of a fixed cutoff, specificity, PPV, and NPV improved without sacrificing sensitivity when applying modified cutoff. In conclusion, our findings suggest that AFP with modified cutoffs according to the individual's hepatitis status might be a useful screening marker for HCC in hepatitis prevalent areas.

摘要

本研究的目的是根据肝炎状态建立血清甲胎蛋白(AFP)的修正临界值。虽然AFP被用作肝细胞癌(HCC)诊断或监测的血清标志物,但其作为普通人群筛查方法的应用存在争议。我们评估了其在肝炎流行的东亚人群中的筛查性能,并根据个体的肝炎状态提出不同的临界值。我们评估了2012年3月至2013年8月期间在单个机构接受常规健康检查的48123名连续韩国人AFP作为筛查试验的性能。使用固定临界值以及根据个体肝炎状态的修正临界值计算敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)。48123名受试者中有24名(0.05%)在筛查后被新诊断为HCC。在1874名乙型肝炎病毒表面抗原(HBsAg)阳性的受试者中,17名(0.91%)发生了HCC,相比之下,丙型肝炎病毒抗体(抗-HCV)阳性的393名个体中有2名(0.51%)发生了HCC。45855名既无HBsAg也无抗-HCV的受试者中有5名(0.01%)发生了HCC。与固定临界值的性能相比,应用修正临界值时特异性、PPV和NPV在不牺牲敏感性的情况下得到了改善。总之,我们的研究结果表明,根据个体肝炎状态采用修正临界值的AFP可能是肝炎流行地区HCC的一种有用筛查标志物。

相似文献

1
Evaluation of alpha-fetoprotein as a screening marker for hepatocellular carcinoma in hepatitis prevalent areas.在肝炎高发地区评估甲胎蛋白作为肝细胞癌筛查标志物的作用。
Ann Hepatol. 2015 Nov-Dec;14(6):882-8. doi: 10.5604/16652681.1171776.
2
Serum alpha-fetoprotein may have a significant role in the surveillance of hepatocellular carcinoma in hepatitis B endemic areas.血清甲胎蛋白在乙肝流行地区肝细胞癌的监测中可能具有重要作用。
Hepatogastroenterology. 2015 Mar-Apr;62(138):327-32.
3
Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model.丙型肝炎病毒感染合并肝细胞癌的早期检测:一种数学模型。
World J Gastroenterol. 2016 Apr 28;22(16):4168-82. doi: 10.3748/wjg.v22.i16.4168.
4
Comparison of AFP-L3 and p53 Antigen Concentration with Alpha-Fetoprotein as Serum Markers for Hepatocellular Carcinoma.甲胎蛋白异质体L3和p53抗原浓度与甲胎蛋白作为肝细胞癌血清标志物的比较
Clin Lab. 2016;62(6):1121-9. doi: 10.7754/clin.lab.2015.151102.
5
Higher Ratio of Serum Alpha-Fetoprotein Could Predict Outcomes in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma and Normal Alanine Aminotransferase.较高的血清甲胎蛋白比率可预测乙肝病毒相关性肝细胞癌且丙氨酸转氨酶正常患者的预后。
PLoS One. 2016 Jun 15;11(6):e0157299. doi: 10.1371/journal.pone.0157299. eCollection 2016.
6
Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma.异常凝血酶原和甲胎蛋白在乙型肝炎病毒相关性肝细胞癌中的诊断价值
World J Gastroenterol. 2015 Apr 7;21(13):3928-35. doi: 10.3748/wjg.v21.i13.3928.
7
Community-based screening for hepatocellular carcinoma in elderly residents in a hepatitis B- and C-endemic area.在乙型肝炎和丙型肝炎流行地区,对老年居民进行基于社区的肝细胞癌筛查。
J Gastroenterol Hepatol. 2011 Jan;26(1):129-34. doi: 10.1111/j.1440-1746.2010.06476.x.
8
The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance.血清甲胎蛋白对肝细胞癌的预测能力与监测目标人群的特征有关。
J Surg Oncol. 2007 Jun 15;95(8):645-51. doi: 10.1002/jso.20653.
9
Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.慢性肝炎、肝硬化和肝细胞癌患者的去γ-羧基凝血酶原、甲胎蛋白和甲胎蛋白-L3
J Gastroenterol Hepatol. 2008 Oct;23(10):1541-8. doi: 10.1111/j.1440-1746.2008.05395.x. Epub 2008 Apr 19.
10
Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase.丙氨酸转氨酶正常的丙型肝炎肝硬化患者中血清甲胎蛋白对肝细胞癌诊断性能的改善
Cancer Epidemiol Biomarkers Prev. 2017 Jul;26(7):1085-1092. doi: 10.1158/1055-9965.EPI-16-0747. Epub 2017 Mar 3.

引用本文的文献

1
Comparison of a multitarget blood test to ultrasound and alpha-fetoprotein for hepatocellular carcinoma surveillance: Results of a network meta-analysis.多靶点血液检测与超声及甲胎蛋白用于肝细胞癌监测的比较:一项网络荟萃分析的结果。
Hepatol Commun. 2022 Oct;6(10):2925-2936. doi: 10.1002/hep4.2045. Epub 2022 Aug 9.
2
A polygenic risk score for nasopharyngeal carcinoma shows potential for risk stratification and personalized screening.多基因风险评分可用于鼻咽癌的风险分层和个体化筛查。
Nat Commun. 2022 Apr 12;13(1):1966. doi: 10.1038/s41467-022-29570-4.
3
The Serious Challenge of Occult Hepatitis B Virus Infection-Related Hepatocellular Carcinoma in China.
隐匿性乙型肝炎病毒感染相关肝细胞癌在中国面临的严峻挑战
Front Microbiol. 2022 Feb 7;13:840825. doi: 10.3389/fmicb.2022.840825. eCollection 2022.
4
MiR-1179 represses cell proliferation, migration and invasion of hepatocellular carcinoma through suppression of NUAK2.微小RNA-1179通过抑制NUAK2来抑制肝细胞癌的细胞增殖、迁移和侵袭。
Am J Transl Res. 2022 Jan 15;14(1):223-239. eCollection 2022.
5
Role of lncRNA LINC01194 in hepatocellular carcinoma via the miR-655-3p/SMAD family member 5 axis.长链非编码 RNA LINC01194 通过 miR-655-3p/SMAD 家族成员 5 轴在肝细胞癌中的作用。
Bioengineered. 2022 Jan;13(1):1115-1125. doi: 10.1080/21655979.2021.2017678.
6
Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients.血浆白细胞介素-17 和甲胎蛋白联合有效预测肝硬化患者肝细胞癌的发生。
BMC Gastroenterol. 2021 Apr 17;21(1):177. doi: 10.1186/s12876-021-01761-1.
7
Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.腹部超声和甲胎蛋白检测用于诊断慢性肝病成人的肝细胞癌。
Cochrane Database Syst Rev. 2021 Apr 15;4(4):CD013346. doi: 10.1002/14651858.CD013346.pub2.
8
A liquid biopsy assay for identifying early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals.一种用于在无症状HBsAg血清阳性个体中识别早期肝细胞癌的液体活检检测方法。
Mol Cell Oncol. 2019 May 28;6(5):e1614419. doi: 10.1080/23723556.2019.1614419. eCollection 2019.
9
Detection of early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals by liquid biopsy.液体活检在无症状 HBsAg 阳性个体中早期检测肝细胞癌。
Proc Natl Acad Sci U S A. 2019 Mar 26;116(13):6308-6312. doi: 10.1073/pnas.1819799116. Epub 2019 Mar 11.
10
Identification of a role for serum aldo-keto reductase family 1 member B10 in early detection of hepatocellular carcinoma.血清醛糖酮还原酶家族1成员B10在肝细胞癌早期检测中的作用鉴定
Oncol Lett. 2018 Dec;16(6):7123-7130. doi: 10.3892/ol.2018.9547. Epub 2018 Oct 3.